Day Case Laparoscopic Sacrocolpopexy, a New Management

Pelvic organ prolapse (POP) is an increasingly common functional disorder which affects approximately 40% of female population. Of these 12% are symptomatic and suffer of physical and emotional distress. 11% will undergo a surgical procedure. Since its introduction by Lane in 1982, Sacrocolpopexy (SCP) became the surgical "gold standard" for correcting vaginal vault .

With minimal invasive approach, SCP had an mean hospitalization time of 3 to 7 days .

With rising health care cost and its inherent economic burden, safe and viable options to reduce cost must be sought.

Day case surgery has developed rapidly in the USA since the 1970s, and has spread to Europe, especially in Great Britain. But the High Authority of Health in France found a delay in its development.

In view of the evolution of surgical and anesthetic techniques, and the low complication rate of SCP, it seemed natural to imagine that this intervention could be done in an ambulatory setting.

Inclusion criteria

• Patients with symptomatic anterior, apical and/or posterior compartment prolapse
• Patients with stage 2 or greater, according to the POP-Q classification
• Patients with a body mass index (BMI) < 30
• Patients with an American Society of Anesthesiologist (ASA) score < ou = 3.

Exclusion criteria

• Patient with prior history of pelvic cancer surgery and radiotherapy of the pelvis